Thus, the presence and association of DHPS, but not DHFR, gene mutations with the use of specific PCP prophylaxis regimens argue strongly both for the importance of SMX and dapsone against Pneumocystis and the central role of DHPS mutations in the potential development of TMP-SMX or dapsone resistance. The gene discussed is DHPS; the disease is pneumocystosis.